PAHC•benzinga•
Phibro Animal Health's Return On Capital Employed Insights
Summary
Pulled from Benzinga Pro data, Phibro Animal Health (NASDAQ:PAHC) showed a loss in earnings since Q3, totaling $7.49 million. Sales, on the other hand, increased by 6.55% to $255.30 million during Q4.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga